J and J Agrees to Acquire Ollin Biosciences

Johnson & Johnson agreed to buy Ollin for $2.2 billion upfront plus up to about $1.125 billion in regulatory and commercial milestones. A separate Blackstone agreement would provide $750 million over multiple years for…




